Login / Signup

Letter to the Editor on: "Population Pharmacokinetics of Dalbavancin and Dosing Considerations for Optimal Treatment of Adult Patients with Staphylococcal Osteoarticular Infections".

S BakloutiS MarolleauP ChavanetE Bonnetnull ConcordetPeggy Gandia
Published in: Antimicrobial agents and chemotherapy (2021)
Dear Editor, Recently, Cojutti et al. [1] published a population pharmacokinetic (POP PK) model on dalbavancin administered to adult patients with Staphylococcal osteoarticular infections (OAI).….
Keyphrases
  • staphylococcus aureus
  • methicillin resistant staphylococcus aureus
  • randomized controlled trial
  • combination therapy